Related Experiment Videos
Laparoscopic Heller myotomy for achalasia.
Robert N Cacchione1, Dan N Tran, Diane H Rhoden
1Department of Surgery, University of Louisville School of Medicine, 2nd Floor ACB, Louisville, KY 40202, USA. Robert.cacchione@louisville.edu
American Journal of Surgery
|July 19, 2005
Summary
Laparoscopic Heller myotomy is a safe option for achalasia patients who failed other treatments. This surgery showed acceptable rates of symptom recurrence and reflux in a recent study.
Area of Science:
- Gastroenterology
- Surgical Innovation
Background:
- Achalasia is a rare esophageal motility disorder affecting 1 in 100,000 individuals annually.
- Potential etiologies include viral, autoimmune, and hereditary factors.
- Established treatments include medications, botulinum toxin, pneumatic dilation, and surgical myotomy.
Purpose of the Study:
- To evaluate the safety and efficacy of laparoscopic-modified Heller myotomy in patients with achalasia.
- To assess outcomes in a patient population with a history of treatment failure.
Main Methods:
- Retrospective review of patients undergoing laparoscopic-modified Heller myotomy at a major surgical center.
- Analysis of patient data including prior treatments, immediate complications, and long-term outcomes.
Main Results:
- 36 patients were identified; 30 had prior treatments (botulinum toxin, dilation, prior myotomy, stenting).
- Immediate complications included mucosal perforation (2), spleen injury (1), and trocar-site infection (1). No postoperative leaks occurred.
- 9 months post-surgery, 3 patients experienced reflux requiring daily PPIs, and 3 had recurrent dysphagia.
Conclusions:
- Laparoscopic Heller myotomy appears to be a safe procedure for achalasia patients, even those with prior treatment failures.
- The rate of recurrent symptoms and reflux in this challenging patient group was not higher than expected.
- Further data are needed to establish an ideal management strategy for achalasia.